IL6 and gastric cancer: The impact of trastuzumab (10 μg/mL), LES-6400 (1 μM), doxorubicin (1 μM), and their combinations (trastuzumab with LES-6400 or doxorubicin) on the concentration of IL-6 in AGS human gastric cancer cells was examined.